Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor David Jackson has been awarded the Rooster Prize by the International Society for Hyaluronan Sciences (ISHAS) and the Gasparo Aselli Medal by the International Society of Lymphology (ISL).

This year, Professor David Jackson was presented with two lifetime achievement awards.

In June, he was awarded the Rooster Prize by the International Society for Hyaluronan Sciences (ISHAS) at their biennial conference in Portland for his work on the structure and function of hyaluronan receptors. The Rooster Prize was established in 2003 and honours those who have made a significant contribution to the hyaluronan field in applied, basic or clinical sciences. It was called the Rooster Prize because, at that time, extremely pure hyaluronan molecules with very high average molecular weight for therapeutic use could be prepared only from rooster combs.

Rooster Prize.jpg

 

In September, he was also presented with the Gasparo Aselli Medal by the International Society of Lymphology (ISL) at the 29th World Congress in Genoa for major contributions to the field of Lymphatics in Immunity and Cancer.

Professor Jackson said: “I’m delighted to have received these two prestigious awards and look forward to continuing my fundamental research into the mechanisms of immune and tumour cell trafficking in the lymphatics with the support of the Radcliffe Department of Medicine, the UK Research Councils and my many excellent collaborators.”

Many congratulations to Professor Jackson!

Similar stories

Immune sensor can detect viral infection by monitoring cell’s own RNA

A recent study by the Rehwinkel Group and collaborators reveals a new way the immune sensor MDA5 can recognise viral infection – not only through viral RNA, but by monitoring changes to the cell’s own RNA processing.

New technology helps decode the genetic changes behind disease

RDM researchers have developed a new technology that can reveal new therapeutic targets from common genetic variants linked to disease.

Virtual Open Day for Graduate Students 20 October 2026

Join our online session to learn more about preparing a strong application for an RDM graduate course.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Professor Marella de Bruijn receives MRC Programme Award

Congratulation to Professor de Bruijn, who has been awarded funding from the UKRI Medical Research Council to investigate how the first blood stem cells formed in the embryo acquire their exceptional regenerative potential, with the aim of informing future stem cell therapies.

How body fat is stored across organs may reveal hidden health risks, study suggests

University of Oxford researchers have found that how fat accumulates in the body is just as important for identifying different health risks as a person’s overall weight.

Similar stories

Immune sensor can detect viral infection by monitoring cell’s own RNA

A recent study by the Rehwinkel Group and collaborators reveals a new way the immune sensor MDA5 can recognise viral infection – not only through viral RNA, but by monitoring changes to the cell’s own RNA processing.

New technology helps decode the genetic changes behind disease

RDM researchers have developed a new technology that can reveal new therapeutic targets from common genetic variants linked to disease.

Virtual Open Day for Graduate Students 20 October 2026

Join our online session to learn more about preparing a strong application for an RDM graduate course.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Professor Marella de Bruijn receives MRC Programme Award

Congratulation to Professor de Bruijn, who has been awarded funding from the UKRI Medical Research Council to investigate how the first blood stem cells formed in the embryo acquire their exceptional regenerative potential, with the aim of informing future stem cell therapies.

How body fat is stored across organs may reveal hidden health risks, study suggests

University of Oxford researchers have found that how fat accumulates in the body is just as important for identifying different health risks as a person’s overall weight.